Company intelligence / Profile preview

PLANTON

Kiel, Schleswig-Holstein, Germanyplantonorganic.com ↗

Ownership: Private
Development stage: Other

Overview

PLANTON completed a Phase 1 clinical trial of recombinant human β-defensin 2 cream in patients with atopic dermatitis to assess safety and efficacy against Staphylococcus aureus and other skin infections. The company is also a leading provider of accredited laboratory analysis services for food, feed, seed, water, health products, pesticides, GMOs, mycotoxins, allergens and more. It holds patents such as the European patent for in ovo sex determination in poultry.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Recombinant protein
Industry: Biotech

Drug pipeline

2 assets

recombinant human beta-defensin 2

Unknown

1 more asset in the full pipeline.

Request access →

Partnerships

ALDI uses PLANTON technology for poultry sex determination

Beyond the preview

Go deeper on PLANTON.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PLANTON.

Explore the full profile